Werewolf Therapeutics
Werewolf Therapeutics is a Massachusetts-based biopharmaceutical company that researches, develops, and commercializes immune therapeutics for the treatment of cancer.
Business Model:
Revenue: $9.1M
Employees: 11-50
Industries / Tags:
Detailed Werewolf Therapeutics Information
Geographic Data
Address: 1030 Massachusetts Avenue
City: Cambridge
State: MA
Zip: 02138
Country: US
Financial Info
Stage:
series b
Raised Last:
$72M
Raised Total:$128M
Social
Metrics
4,536,816Website Global Rank
2,083Website Monthly Traffic
Twitter Followers
Description
Werewolf Therapeutics is a Massachusetts-based biopharmaceutical company that researches, develops, and commercializes immune therapeutics for the treatment of cancer.
Contact Phone:
+16179520555
Contact Email:
Werewolf Therapeutics went public on 4/29/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/29/2021
IPO Valuation:
$441M
Ticker Symbol:
HOWL
IPO Price:
$16/share
Amount Raised:
$120M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
